PharmaCyte Biotech today announced that it has successfully completed a study on the stability after “hand thawing” syringes of the Cell-in-a-Box® encapsulated cells that will be used, in combination with low doses of the cancer prodrug ifosfamide, for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer.
July 23, 2018
· 5 min read